FDA NDC Directory · JSON-LD · Markdown

Famotidine

NDC 0832-6045 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerUpsher-Smith Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA217655
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsFAMOTIDINE (40 mg/5mL)
Marketing started20230616
Package count3

External sources

Source: openFDA. Public-domain (CC0).